Jushi Holdings (JUSHF) Acquisitions (2021 - 2022)

Jushi Holdings' (JUSHF) quarterly Acquisitions came in at $86000.0 in Q4 2022, up 26.47% on a QoQ basis from $68000.0 in Q3 2022.

Jushi Holdings (JUSHF) Acquisitions (2021 - 2022) Analysis & Trends

Jushi Holdings (JUSHF) has 2 years of Acquisitions data on file, last reported at $86000.0 in Q4 2022.

On a quarterly basis, Acquisitions changed N/A year-over-year to $86000.0 in Q4 2022; TTM through Sep 2023 was $86000.0, a 99.59% decrease from a year earlier, with the FY2022 full-year figure at $21.0 million, down 55.66% from the prior year.
Acquisitions for Q4 2022 stood at $86000.0, up from $68000.0 in the prior quarter.
Over the last five years, Acquisitions for JUSHF reached as high as $42.1 million in Q3 2021 and fell as low as $68000.0 in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	-
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	-
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	-
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	-
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-
10	Jushi Holdings	81.25 Mn	41.54 Mn	29.88 Mn	-

Download Data